#SFHP2610575AOrder of April 16, 2026, Amending the Order of October 29, 2009, Related to Medicinal Products for Human Use Classified in One of the Restricted Prescription Categories for the Application of Article R. 5141-122 of the Public Health Code
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
This law allows veterinary clinics and hospitals in France access to certain human medicines specified in annexes, provided they are not facing supply shortages. It impacts veterinarians by enabling them to use human medicines for animals, with conditions on dealing with supply issues. It requires action from the pharmaceutical supply chain to ensure availability isn't affected and from veterinarians to monitor reports on medicine shortages.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Veterinary clinics can access specific human medicines if not under supply constraints.
- Annexes listing accessible medicines are updated.
- Pharmaceutical establishments must suspend supply to veterinarians if shortages occur.
Obligations
What this law requires
Veterinary clinics and hospitals must access and use human medicines listed in Annexes I to III as specified in the modified arrêté.
Veterinarians must monitor the reports on medicine shortages published on the website of the Agence nationale de sécurité du médicament et des produits de santé.
Pharmaceutical suppliers must ensure that the supply of medicines specified in the annexes is not affected by shortages.
Pharmaceutical establishments must suspend the delivery of listed specialties to veterinarians when these specialties face supply issues as reported on the Agence nationale de sécurité du médicament et des produits de santé website.
Veterinarians who wish to use anticancer medications must submit a declaration as specified in Article R. 5141-112-3 of the Code de la santé publique.